Particle Sciences Inc. (PSI) and SoluBest have entered into a licensing and technology development agreement under which PSI will be the exclusive contract research provider in the U.S. for SoluBest’s Solumer technology. PSI will offer Solumer formulation and clinical trial supply manufacturing to pharma/biopharma companies. The Solumer approach uses GRAS polymers to create drug/polymer complexes that, according to the company, result in greatly improved drug solubility and bioavailability...